Αποτελέσματα Αναζήτησης
Covidien is now Medtronic Minimally Invasive Therapies. Our medical devices and supplies work across the care continuum — to diagnose earlier, intervene earlier, treat better and help patients recover faster.
- Clinical Solutions
Building 9, Croxley Park. Hatters Lane. Watford, WD18 8WW....
- Patient Information
Patient Information Empower yourself. Understand your...
- Clinical Solutions
Our industry-leading acute care and monitoring technologies make it possible for clinicians to predict, respond to, and prevent potential adverse events — to help keep your patients safe wherever you are.1–5. We empower healthcare professionals with world-class technology to personalize patient care, anytime, anywhere.
17 Σεπ 2014 · The $43 billion acquisition of Covidien (NYSE: COV) by Medtronic (NYSE: MDT) flunks M&A 101, but looking at the deal by the book is the wrong way to think about it, a senior Medtronic...
16 Ιουν 2014 · Medtronic (NYSE:MDT) announced a $42.9 billion deal to acquire rival medical device maker Covidien (NYSE:COV), creating a formidable competitor to Johnson & Johnson’s (NYSE:JNJ) device business.
16 Ιουν 2014 · US medical device maker Medtronic is to buy Irish Republic-based Covidien in a $42.9bn (£25.3bn) cash and shares deal. Medtronic's wide portfolio includes heart stents and surgical tools.
16 Ιουν 2014 · Medtronic, which has a market value of $60.5bn, will pay Covidien shareholders $93.22 a share. That represents a premium of 50 per cent over Friday’s closing stock price of $60.70, marking the...
With the deal in the books, attention now turns to what will be a challenging three-year process of integrating Covidien's $10 billion in surgical supplies with Medtronic's $17 billion of...
